23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the "Board") completed its previously announced review ...

23andMe Holding Co. ( ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, ...

Review of Strategic Alternatives Throughout the review process, the Board, in collaboration with its financial and legal advisors, evaluated potential strategic opportunities, including a possible ...

The top management of the tour operator AB Novaturas (hereinafter referred to as Novaturas) has passed a decision to conduct an analysis of strategic alternatives. For this purpose, a contract was ...

23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter results that showed an 8% drop in consumer services revenue year over year.

The top management of the tour operator AB Novaturas (hereinafter referred to as Novaturas) has passed a decision to conduct an analysis of strategic alternatives. For this purpose, a contract was sig ...

The Special Committee of the Board of Directors of 23andMe Holding Co. (Nasdaq: ME) ("23andMe" or the "Company"), a leading human genetics company ...